Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study.

Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF.

Neuropsychopharmacology. 2009 Jun;34(7):1810-8. doi: 10.1038/npp.2009.2. Epub 2009 Feb 4.

3.

Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression.

Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, Falini A, Radaelli D, Scotti G, Smeraldi E.

Psychiatry Res. 2009 Sep 30;173(3):238-42. doi: 10.1016/j.pscychresns.2008.08.004. Epub 2009 Aug 13.

PMID:
19682864
4.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
5.

A Longitudinal (6-week) 3T (1)H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression.

Machado-Vieira R, Gattaz WF, Zanetti MV, De Sousa RT, Carvalho AF, Soeiro-de-Souza MG, Leite CC, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2311-7. doi: 10.1016/j.euroneuro.2015.08.023. Epub 2015 Sep 25.

PMID:
26428274
6.

A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder.

Chitty KM, Lagopoulos J, Lee RS, Hickie IB, Hermens DF.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1348-63. doi: 10.1016/j.euroneuro.2013.07.007. Epub 2013 Aug 2. Review.

PMID:
23968965
7.

Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.

Ongür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF.

Biol Psychiatry. 2008 Oct 15;64(8):718-26. doi: 10.1016/j.biopsych.2008.05.014. Epub 2008 Jul 7.

8.

The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.

Murck H, Schubert MI, Schmid D, Schüssler P, Steiger A, Auer DP.

J Psychiatr Res. 2009 Jan;43(3):175-80. doi: 10.1016/j.jpsychires.2008.04.009. Epub 2008 Jun 3.

PMID:
18533184
9.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Lyoo IK, Renshaw PF.

J Affect Disord. 2007 Apr;99(1-3):19-25. Epub 2006 Sep 26.

10.

Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression.

Frye MA, Watzl J, Banakar S, O'Neill J, Mintz J, Davanzo P, Fischer J, Chirichigno JW, Ventura J, Elman S, Tsuang J, Walot I, Thomas MA.

Neuropsychopharmacology. 2007 Dec;32(12):2490-9. Epub 2007 Apr 11.

11.

A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression.

Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG Jr, Renshaw PF, Cohen BM.

J Clin Psychopharmacol. 2013 Oct;33(5):627-35. doi: 10.1097/JCP.0b013e31829a83f5.

12.

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG Jr, Renshaw PF, Ongür D.

Neuropsychopharmacology. 2010 Feb;35(3):834-46. doi: 10.1038/npp.2009.191. Epub 2009 Dec 2.

13.

Could glutamate spectroscopy differentiate bipolar depression from unipolar?

Taylor MJ.

J Affect Disord. 2014;167:80-4. doi: 10.1016/j.jad.2014.05.019. Epub 2014 May 23.

PMID:
25082118
14.

Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C, Vallada H, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2221-9. doi: 10.1016/j.euroneuro.2015.09.020. Epub 2015 Oct 9.

PMID:
26476706
15.

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN.

Bipolar Disord. 2012 Aug;14(5):478-87. doi: 10.1111/j.1399-5618.2012.01033.x. Review.

PMID:
22834460
16.
17.

Brain GABA levels in patients with bipolar disorder.

Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):427-34. doi: 10.1016/j.pnpbp.2008.12.025. Epub 2009 Jan 10.

PMID:
19171176
18.

Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.

Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, Ryan CM, Kim JE, Renshaw PF, Jacobson AM.

Arch Gen Psychiatry. 2009 Aug;66(8):878-87. doi: 10.1001/archgenpsychiatry.2009.86.

PMID:
19652127
19.

Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse.

O'Neill J, Tobias MC, Hudkins M, London ED.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu059. doi: 10.1093/ijnp/pyu059.

20.

Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.

Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C, Canive J, Gasparovic C.

JAMA Psychiatry. 2014 Mar;71(3):265-72. doi: 10.1001/jamapsychiatry.2013.3939.

PMID:
24402128

Supplemental Content

Support Center